New Drug Approvals Archive - October 2012
Get news by email or subscribe to our news feeds.
October 2012
| October 2 |
Cystaran (cysteamine hydrochloride) Ophthalmic Solution - formerly CystoranDate of Approval: October 2, 2012
Company: Sigma-Tau Pharmaceuticals, Inc.
Treatment for: Cystinosis
Cystaran (cysteamine cysteamine ophthalmic solution) is a cystine-depleting agent indicated for the treatment of corneal cystine crystal accumulation in patients with cystinosis. Cystaran (cysteamine hydrochloride) FDA Approval History |
| October 12 |
Abraxane (paclitaxel protein-bound)
New Indication Approved: October 11, 2012
Abraxane (paclitaxel protein-bound) FDA Approval History |
| October 17 |
Jetrea (ocriplasmin) Intravitreal Injection Date of Approval: October 17, 2012
Company: ThromboGenics NV
Treatment for: Vitreomacular Adhesion
Jetrea (ocriplasmin) is a proteolytic enzyme indicated for the treatment of symptomatic vitreomacular adhesion. Jetrea (ocriplasmin) FDA Approval History |
| October 22 |
Fycompa (perampanel) Tablets and Oral Suspension Date of Approval: October 22, 2012
Company: Eisai Inc.
Treatment for: Epilepsy, Seizures
Fycompa (perampanel) is a non-competitive AMPA glutamate receptor antagonist indicated as adjunctive therapy for the treatment of partial-onset seizures and primary generalized tonic-clonic (PGTC) seizures in patients with epilepsy. Fycompa (perampanel) FDA Approval History |
| October 26 |
Synribo (omacetaxine mepesuccinate) - formerly OmaproDate of Approval: October 26, 2012
Company: Teva Pharmaceuticals
Treatment for: Chronic Myelogenous Leukemia
Synribo (omacetaxine mepesuccinate) is a first-in-class small molecule drug for the treatment of adult patients with chronic or accelerated phase chronic myeloid leukemia. Synribo (omacetaxine mepesuccinate) FDA Approval History |
| September 24 |
New Indication Approved: September 23, 2014
Minivelle (estradiol) FDA Approval History |
| June 22 |
New Indication Approved: June 19, 2015
Fycompa (perampanel) FDA Approval History |
| May 2 |
New Dosage Form Approved: May 2, 2016
Fycompa (perampanel) FDA Approval History |
New Drug Approvals Archive
2016
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2015
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2014
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2013
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2012
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2011
January,
February,
March,
April,
May,
June,
July,
August,
October,
November,
December2010
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2009
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2008
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2007
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2006
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2005
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2004
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2003
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December
